Prescription drug · NDA
Neurontin (Gabapentin) NDC 0071-0805
Gabapentin 300 mg/1 · Capsule · Oral · Parke-Davis Div of Pfizer Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0071-0805-24 | 00071080524 | 100 CAPSULE in 1 BOTTLE (0071-0805-24)Marketed from Dec 30, 1993 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Neurontin
- Generic name (nonproprietary)
- gabapentin
- Active ingredients
- Gabapentin — 300 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Parke-Davis Div of Pfizer IncNDC labeler code 0071
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 020235
- Marketing start
- Marketing end
- Other FDA classes
- Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
- Identifiers
- Product ID 0071-0805_e730d5df-d47b-4d7f-ae3b-bd449f6b1213SPL ID e730d5df-d47b-4d7f-ae3b-bd449f6b1213SPL set ID ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388RxCUI 105028, 105029, 105030, 261280, 261281, 283523, 310430, 310431, 310432, 310433, 310434, 351973UNII 6CW7F3G59XUPC 0300710513242
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400071080524followed by a unit qualifier and the quantityPackage 00071-0805-24. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
NEURONTIN ® is indicated for: • Management of postherpetic neuralgia in adults • Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy NEURONTIN is indicated for: • Postherpetic neuralgia in adults ( 1 ) • Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 0071-0805
- What is NDC 0071-0805?
- 0071-0805 is the product NDC for Neurontin (gabapentin), Gabapentin 300 mg/1 capsule, listed with the FDA by Parke-Davis Div of Pfizer Inc. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Neurontin (Gabapentin).
- What is the active ingredient?
- Gabapentin.
- Who is the labeler?
- Parke-Davis Div of Pfizer Inc, NDC labeler code 0071. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Neurontin?
- 7 other product NDCs are listed under this name. See all Neurontin NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Neurontin products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Neurontingabapentin | Gabapentin 300 mg/1 | CapsuleOral | Viatris Specialty LLC | 58151-282 | 58151-0282-01 |
| Neurontingabapentin | Gabapentin 250 mg/5mL | SolutionOral | Viatris Specialty LLC | 58151-290 | 58151-0290-35 |
| Neurontingabapentin | Gabapentin 600 mg/1 | Tablet, Film coatedOral | Viatris Specialty LLC | 58151-284 | 58151-0284-01 |
| Neurontingabapentin | Gabapentin 400 mg/1 | CapsuleOral | Viatris Specialty LLC | 58151-283 | 58151-0283-01 |
| Neurontingabapentin | Gabapentin 800 mg/1 | Tablet, Film coatedOral | Viatris Specialty LLC | 58151-285 | 58151-0285-01 |
| Neurontingabapentin | Gabapentin 100 mg/1 | CapsuleOral | Viatris Specialty LLC | 58151-281 | 58151-0281-01 |
| Neurontingabapentin | Gabapentin 250 mg/5mL | SolutionOral | Parke-Davis Div of Pfizer Inc | 0071-2012 | 00071-2012-47 |
Other NDCs under NDA 020235
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Neurontingabapentin | Gabapentin 100 mg/1 | CapsuleOral | Viatris Specialty LLC | 58151-281 |
| Neurontingabapentin | Gabapentin 300 mg/1 | CapsuleOral | Viatris Specialty LLC | 58151-282 |
| Neurontingabapentin | Gabapentin 400 mg/1 | CapsuleOral | Viatris Specialty LLC | 58151-283 |